Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938170 · ClinicalTrials.gov registry record · NA
Home Administration of FluMist by Parents/Caregivers
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01938170 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 41 participants.
The verdict
NCT01938170, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study will examine the feasibility of having parents and caregivers administer FluMist live intranasal vaccine to their children at home outside the traditional medical environment and without the involvement of medical personnel. The study will recruit patients and families that are already eligible to receive the FluMist vaccine. After consent is obtained and vaccine is given to the family, they will go home to administer vaccine to other members within 24 hours. Telephone follow up within 48 hours will confirm that vaccine was given successfully and within 9-12 days to assess patient preferences for giving vaccine at home and if there were any adverse events.
Interventions
- BIOLOGICAL FluMist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938170
The ClinicalTrials.gov registry entry for NCT01938170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FluMist is the first listed.
NCT01938170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938170 about?
NCT01938170 is a clinical study titled "Home Administration of FluMist by Parents/Caregivers". This study will examine the feasibility of having parents and caregivers administer FluMist live intranasal vaccine to their children at home outside the traditional medical environment and without the involvement of medical personnel. The study will recruit patients and families that are already e...
What is the current status of trial NCT01938170?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-09. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01938170?
The interventions under investigation include: FluMist (BIOLOGICAL).
Who is sponsoring clinical trial NCT01938170?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.